149 related articles for article (PubMed ID: 38201465)
1. Validation of the "Rome" Classification for Squamous Cell Carcinoma of the Nasal Vestibule.
Scheurleer WFJ; de Ridder M; Tagliaferri L; Crescio C; Parrilla C; Mattiucci GC; Fionda B; Deganello A; Galli J; de Bree R; Rijken JA; Bussu F
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201465
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma of the nasal vestibule in the Netherlands: A clinical and epidemiological review of 763 cases (2008-2021).
van de Velde LJ; Scheurleer WFJ; Braunius WW; Devriese LA; de Ridder M; de Bree R; Breimer GE; van Dijk BA; Rijken JA
Head Neck; 2024 Jul; 46(7):1809-1821. PubMed ID: 38511478
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Staging Systems for Cancer of the Nasal Vestibule.
Scheurleer WFJ; Tagliaferri L; Rijken JA; Crescio C; Rizzo D; Mattiucci GC; Pameijer FA; de Bree R; Fionda B; de Ridder M; Bussu F
Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37296990
[TBL] [Abstract][Full Text] [Related]
4. Long-term oncological follow-up after mold-based pulsed dose rate brachytherapy for early stage squamous cell carcinoma of the nasal vestibule: A single center experience of 68 patients over a 17-year period.
Scheurleer WFJ; Dehnad H; Braunius WW; Janssen LM; Tijink BM; Breimer GE; Smid EJ; Devriese LA; Bree R; Ridder M; Rijken JA
Brachytherapy; 2023; 22(2):221-230. PubMed ID: 36539317
[TBL] [Abstract][Full Text] [Related]
5. Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma.
Brkic FF; Kadletz L; Jank B; Mayer C; Heiduschka G; Brunner M
J Craniomaxillofac Surg; 2020 Jan; 48(1):33-37. PubMed ID: 31810849
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators in carcinoma of the nasal vestibule.
Jeannon JP; Riddle PJ; Irish J; O'sullivan B; Brown DH; Gullane P
Clin Otolaryngol; 2007 Feb; 32(1):19-23. PubMed ID: 17298305
[TBL] [Abstract][Full Text] [Related]
7. Nasal vestibule squamous cell carcinoma: a population-based cohort study from DAHANCA.
Filtenborg MV; Lilja-Fischer JK; Sharma MB; Primdahl H; Kjems J; Plaschke CC; Charabi BW; Kristensen CA; Andersen M; Andersen E; Godballe C; Johansen J; Overgaard J; Petersen KB
Acta Oncol; 2022 Feb; 61(2):127-133. PubMed ID: 34709956
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma of the nasal vestibule 1993-2002: a nationwide retrospective study from DAHANCA.
Agger A; von Buchwald C; Madsen AR; Yde J; Lesnikova I; Christensen CB; Foghsgaard S; Christensen TB; Hansen HS; Larsen S; Bentzen J; Andersen E; Andersen L; Grau C
Head Neck; 2009 Dec; 31(12):1593-9. PubMed ID: 19475548
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
Abdelmeguid AS; Teeramatwanich W; Roberts DB; Amit M; Ferraroto R; Glisson BS; Kupferman ME; Su SY; Phan J; Garden AS; Raza SM; DeMonte F; Hanna EY
Cancer; 2021 Jun; 127(11):1788-1795. PubMed ID: 33567468
[TBL] [Abstract][Full Text] [Related]
10. A Multicentre UK Study of Outcomes for Locally Advanced Sinonasal Squamous Cell Carcinoma Treated with Adjuvant or Definitive Intensity-modulated Radiotherapy.
Slevin F; Pan S; Mistry H; Denholm M; Shor D; Oong Z; Price J; Jadon R; Fleming JC; Barnett G; Dixon L; Prestwich R; Thomson D
Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):e450-e461. PubMed ID: 34147323
[TBL] [Abstract][Full Text] [Related]
11. New standards for the management of nose vestibule malignancies.
Bussu F; Tagliaferri L; Crescio C; Rizzo D; Gallus R; Parrilla C; Fionda B; Lancellotta V; Mattiucci GC; Galli J
Acta Otolaryngol; 2023 Mar; 143(3):215-222. PubMed ID: 36855802
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Management of Sinonasal Malignancies at a Dedicated Cancer Institution: A Retrospective Study.
Dhanani R; Faisal M; Shahid H; Malik KI; Jamshed A; Hussain R
Ann Maxillofac Surg; 2021; 11(1):115-120. PubMed ID: 34522665
[TBL] [Abstract][Full Text] [Related]
13. Impact of anatomic origin of primary squamous cell carcinomas of the nasal cavity and ethmoidal sinus on clinical outcome.
Janik S; Gramberger M; Kadletz L; Pammer J; Grasl MC; Erovic BM
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2363-2371. PubMed ID: 30027439
[TBL] [Abstract][Full Text] [Related]
14. Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck.
Amit M; Liu C; Netto Gleber FO; Kini S; Tam S; Benov A; Aashiq M; El-Naggar AK; Moreno AC; Rosenthal DI; Glisson BS; Ferrarotto R; Wong MK; Migden MR; Li G; Khanna A; Goepfert RP; Nagarajan P; Weber RS; Myers JN; Gross ND
Eur J Cancer; 2021 Feb; 144():169-177. PubMed ID: 33352413
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapy.
Mourad WF; Hu KS; Shasha D; Concert C; Ishihara D; Lin W; Gamez ME; Lukens JN; Shourbaji RA; Ryniak M; Li Z; Culliney BE; Khorsandi AS; Tran T; Jacobson A; Manolidis S; Schantz S; Urken M; Persky MS; Harrison LB
Anticancer Res; 2013 Dec; 33(12):5511-6. PubMed ID: 24324090
[TBL] [Abstract][Full Text] [Related]
16. New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base.
Thompson LDR; Franchi A
Virchows Arch; 2018 Mar; 472(3):315-330. PubMed ID: 28444451
[TBL] [Abstract][Full Text] [Related]
17. Customized individual applicators for endocavitary brachytherapy in patients with cancers of the nasal cavity, sinonasal region and nasopharynx.
Kadah BA; Niewald M; Papaspyrou G; Dzierma Y; Schneider M; Schick B
Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1543-7. PubMed ID: 25905695
[TBL] [Abstract][Full Text] [Related]
18. Outcome and toxicity profile after brachytherapy for squamous cell carcinoma of the nasal vestibule.
Lipman D; Verhoef LC; Takes RP; Kaanders JH; Janssens GO
Head Neck; 2015 Sep; 37(9):1297-303. PubMed ID: 24838690
[TBL] [Abstract][Full Text] [Related]
19. The role of elective neck dissection in T1 and T2 nasal cavity squamous cell carcinomas.
Lill C; Erovic BM; Seemann R; Faisal M; Stelter K; Gandler B; Frommlet F; Strobl A; Formanek M; Janik S
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1875-1883. PubMed ID: 36342517
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy for nasal vestibule squamous cell carcinoma: a 40-year experience.
Wray J; Morris CG; Kirwan JM; Amdur RJ; Werning JW; Dziegielewski PT; Mendenhall WM
Eur Arch Otorhinolaryngol; 2016 Mar; 273(3):661-9. PubMed ID: 25773487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
